The University of Chicago Header Logo

Connection

Sushila R. Dalal to Kaplan-Meier Estimate

This is a "connection" page, showing publications Sushila R. Dalal has written about Kaplan-Meier Estimate.
Connection Strength

0.037
  1. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.